Dow Up 0.19% Nasdaq Up 0.56%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYSE
142.68 Up 0.21(0.15%) 4:02PM EST
Prev Close:142.47
Open:141.53
Bid:141.56 x 1100
Ask:145.00 x 400
1y Target Est:52.38
Beta:0.58
Next Earnings Date:N/A
Day's Range:140.20 - 144.57
52wk Range:105.17 - 153.10
Volume:2,183,980
Avg Vol (3m):2,643,360
Market Cap:47.89B
P/E (ttm):96.34
EPS (ttm):1.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VRXUp 0.15%47.89B
TEVADown 0.93%48.48B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.95
Ex-Dividend Date:10-Nov-10

Analysts

Annual EPS Est (Dec-10) :N/A
Quarterly EPS Est (Sep-10) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback